Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Retained Earnings (2016 - 2017)

Tenax Therapeutics' Retained Earnings history spans 6 years, with the latest figure at -$5749.0 for Q3 2017.

  • For Q3 2017, Retained Earnings rose 100.0% year-over-year to -$5749.0; the TTM value through Sep 2017 reached -$5749.0, up 100.0%, while the annual FY2016 figure was -$204.7 million, N/A changed from the prior year.
  • Retained Earnings for Q3 2017 was -$5749.0 at Tenax Therapeutics, up from -$210.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $88867.0 in Q2 2016 and bottomed at -$210.9 million in Q2 2017.
  • The 4-year median for Retained Earnings is -$57.7 million (2013), against an average of -$88.2 million.
  • The largest YoY upside for Retained Earnings was 100.0% in 2017 against a maximum downside of 237444.97% in 2017.
  • A 4-year view of Retained Earnings shows it stood at -$115.2 million in 2013, then soared by 99.89% to -$129442.0 in 2015, then tumbled by 158009.12% to -$204.7 million in 2016, then skyrocketed by 100.0% to -$5749.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Retained Earnings are -$5749.0 (Q3 2017), -$210.9 million (Q2 2017), and -$12175.0 (Q1 2017).